SciClone Pharmaceuticals, Inc. (SCLN) Selects rfXcel To Meet China Product Compliance And Anti-Counterfeiting Goal
4/23/2014 7:42:54 AM
SAN RAMON, Calif.--(BUSINESS WIRE)--rfXcel, a leading cloud provider of product serialization, traceability and compliance solutions, announces that SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), a US-based, specialty pharmaceutical company with a substantial commercial business in China, has selected rfXcel Traceability SystemTM (rTS) to meet its China product compliance needs and further advance its ongoing efforts to minimize counterfeiting of its proprietary products in China.
Help employers find you! Check out all the jobs and post your resume.
comments powered by